tiprankstipranks
Clene Unveils Phase 3 Trial Design at NEALS
PremiumCompany AnnouncementsClene Unveils Phase 3 Trial Design at NEALS
1M ago
Clene price target lowered to $86 from $94 at Canaccord
Premium
The Fly
Clene price target lowered to $86 from $94 at Canaccord
2M ago
Clene announces $7.3M registered direct offering, private placements
Premium
The Fly
Clene announces $7.3M registered direct offering, private placements
2M ago
Clene target adjusted to $97 on reverse split at Rodman & Renshaw
PremiumThe FlyClene target adjusted to $97 on reverse split at Rodman & Renshaw
4M ago
Canaccord reiterates Buy rating on Clene following ‘intriguing’ new data
Premium
The Fly
Canaccord reiterates Buy rating on Clene following ‘intriguing’ new data
4M ago
Clene target adjusted to $31 from $7 at H.C. Wainwright
Premium
The Fly
Clene target adjusted to $31 from $7 at H.C. Wainwright
4M ago
Clene announces 1-for-20 reverse stock split
PremiumThe FlyClene announces 1-for-20 reverse stock split
5M ago
Clene presents preliminary data on CNM-Au8 in Rett Syndrome
Premium
The Fly
Clene presents preliminary data on CNM-Au8 in Rett Syndrome
5M ago
Clene Reveals Breakthrough ALS Trial Results and Extended Survival Data
Premium
Company Announcements
Clene Reveals Breakthrough ALS Trial Results and Extended Survival Data
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100